|
|
||||||||
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
Department of Medicine, Division of Infectious Diseases, The Mount Sinai Hospital and Department of Microbiology, One Gustave L. Levy Place, Mount Sinai School of Medicine, New York, NY 10029, USA
Correspondence Edward J. Bottone edward.bottone{at}mssm.edu
Received 9 April 2002 Accepted 18 August 2002
A compound produced by Bacillus pumilus (MSH) that inhibits Mucoraceae and Aspergillus species is described. Fungicidal activity was demonstrated by lawn-spotting and by diffusion through 0.45 µm Millipore membranes placed on 5 % sheep-blood agar, nutrient agar, trypticase soy agar and MuellerHinton agar, followed by spore inoculation of the bacterium-free underlying agar surface. With either technique, zones of fungal inhibition correlated with the zone of haemolysis produced by B. pumilus (MSH). The active compound inhibited Mucor and Aspergillus spore germination and aborted elongating hyphae, presumably by inducing a cell-wall lesion. Antifungal activity was stable in agar for a minimum of 8 days, resistant to Pronase degradation, and partially inactivated by chloroform exposure and at pH 5.6. Its molecular mass was determined by diffusion through dialysis membrane to be 5003000 Da. Attempts at further isolation of the compound have proven unsuccessful to date.
This article has been cited by other articles:
![]() |
V Yadav, R Mandhan, R. Dabur, A K Chhillar, J Gupta, and G L Sharma A fraction from Escherichia coli with anti-Aspergillus properties J. Med. Microbiol., April 1, 2005; 54(4): 375 - 379. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | J MED MICROBIOL | MICROBIOLOGY | J GEN VIROL | ALL SGM JOURNALS |